Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 301 to 310 of 359 resources
-
Health and Social Care Act 2012
The Health and Social Care Act 2012 aims to safeguard the future of the NHS by modernising it to better tackle the problems of today and avoid crisis tomorrow. It sets out a plan to put clinicians at the centre of commissioning, freeing up providers to innovate, empowering patients and giving a new focus to public health.England 27 Mar 2012 Other PDF -
Deaths from liver disease: Implications for end of life care in England - March 2012
This report presents key facts about deaths from liver disease in England. It highlights differences in place and cause of death by age, sex and deprivation. It is aimed at commissioners and providers of end of life care, clinicians caring for patients with liver disease, and others concerned with providing quality end of life care for this patient group, including patients themselves and their carers. The report gives the first summary of high level statistics on deaths from liver disease on which future discussions can be built.England Mar 2012 Reports & Research PDF -
Guidance on testing for hepatitis B and C (with reference to HIV) Developed by Yorkshire and the Humber Hepatitis B and C Steering Group
Individuals with chronic hepatitis (B and C) can be treated, which reduces the likelihood of chronic illness and premature death. Recognition of infection and treatment may also reduce the spread of infection. In 2010 across Yorkshire and the Humber there were 427 cases of hepatitis B (of which 39 were acute) and 980 newly identified hepatitis C infections reported through NHS/HPA laboratory testing, however HPA estimates calculate that there are over 20,000 people actually infected with hepatitis C in the region.Yorkshire and the Humber Mar 2012 Tools & Templates, Strategy & Planning PDF -
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
This paper reports on the results of a 2011 EASL meeting and subsequent dialogue with patient groups and relevant experts in Europe. It summarises the current knowledge of HCV infection and the brain; prevalence, course, and neurobiology of IFN-a associated psychiatric side effects; possible risk factors for IFN-a associated depression and suicide attempts; psychiatric management of HCV infected patients before and during antiviral treatment; prevention of IFN- a associated psychiatric side effects; and psychiatric aspects of the new antivirals.UK, Rest of World 2012 Reports & Research PDF -
Yorkshire and the Humber Quality Standards Framework for Hepatitis B and C: 2012
In order to address the prevention and burden of hepatitis C (and B) effectively it is important that the four key elements of the pathway are in place as defined by the Department of Health. Whilst there have been many developments since 2004, this Quality Standards Framework still focuses on the four key elements of the hepatitis B and C pathway but provides more detail on how, in Yorkshire and the Humber, stakeholders can work effectively to deliver a quality pathway to patients regarding hepatitis B and C.Yorkshire and the Humber 2012 Other, Reports & Research PDF -
Improving outcomes and supporting transparency. Part 1: A public health outcomes framework for England, 2013-2016
The responsibility to improve and protect our health lies with us all – government, local communities and with ourselves as individuals.England Jan 2012 Reports & Research, Strategy & Planning PDF -
The Silent Pandemic: Tackling Hepatitis C with Policy Innovation
Hepatitis C may be the serious disease that most combines widespread prevalence with widespread ignorance. According to the World Health Organisation (WHO), this urgent public health problem kills 350,000 people per year, and 150 million have the chronic form of the hepatitis C virus (HCV). The incidence of new infections is simply not known at the global level. Yet, HCV is entirely preventable and largely curable.UK, Rest of World 2012 Reports & Research PDF -
The Hepatitis C Trust Outreach & Testing Van
This document summarises The Hepatitis C Trust’s Outreach and Testing Van service, which aims to increase diagnoses by reaching groups who may be at risk of hep C but who currently cannot, or do not, access testing through existing means. Given that most people in the UK today are undiagnosed, the testing van aims to overcome some of the key barriers to diagnosis.England 2011 Case study, Reports & Research PDF -
The Sexual Health and Blood Borne Virus Framework 2011-15
Sexual health and blood borne viruses continue to be of high priority for the Scottish Government. The SexualScotland Aug 2011 Reports & Research PDF -
Wirral Drug and Alcohol Addiction Team (DAAT) Hep C Strategy
The National Treatment Agency’s (NTA) aspirational target is for each DAAT partnership to ensure that 100% of their previous/current injecting drug user (IDU) population to have been tested for Hepatitis C. Many DAATs across the country have struggled to achieve this target and Wirral DAAT’s performance at the end of 2007/08 is at 20%.North West 2011 Case study, Strategy & Planning PDF